Concepedia

Thomas Seck

TS

32

Publications

1.6K

Citations

22

H-Index

1998

Active since

Affiliations

Heidelberg University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

BG University Hospital Bergmannsheil Bochum

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (United Kingdom)

Thomas Seck is an author at Heidelberg University specializing in medicine, osteoporosis, and bone metabolism.

Top concepts

Publications per year

1998–2015

32

Publications

32

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

Thomas Seck, Michael A. Nauck, Sheila Sunga et al. · International Journal of Clinical Practice · 2010 · 202 citations

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double‐blind, non‐inferiority trial

Rosario Arechavaleta, Thomas Seck, Yong Chen et al. · Diabetes Obesity and Metabolism · 2010 · 163 citations

Binding of Filamin to the C-terminal Tail of the Calcitonin Receptor Controls Recycling

Thomas Seck, Roland Baron, William C. Horne · Journal of Biological Chemistry · 2003 · 100 citations · Full text

Concentration of Transforming Growth Factor Beta in Human Bone Tissue: Relationship to Age, Menopause, Bone Turnover, and Bone Volume

Johannes Pfeilschifter, Ingo Diel, Beate Scheppach et al. · Journal of Bone and Mineral Research · 1998 · 90 citations · Full text

The effect of initial therapy with the fixed‐dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Charles A. Reasner, Leann Olansky, Thomas Seck et al. · Diabetes Obesity and Metabolism · 2011 · 90 citations

Rows per page

1–5 of 32